COVID-19 vaccine induced interstitial lung disease

A 60-year-old man presented with dyspnea four days after the second dose of the coronavirus disease (COVID-19) vaccine. Imaging revealed extensive ground-glass opacification. Blood tests were notable for elevated KL-6 levels. Bronchoalveolar lavage fluid analysis showed increased lymphocyte-dominant...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshifuji, Ayumi, Ishioka, Kota, Masuzawa, Yuya, Suda, Shuntaro, Murata, Saori, Uwamino, Yoshifumi, Fujino, Motoko, Miyahara, Hiromi, Hasegawa, Naoki, Ryuzaki, Munekazu, Hoshino, Haruhiko, Sekine, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450284/
https://www.ncbi.nlm.nih.gov/pubmed/34580010
http://dx.doi.org/10.1016/j.jiac.2021.09.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450284/
https://www.ncbi.nlm.nih.gov/pubmed/34580010
http://dx.doi.org/10.1016/j.jiac.2021.09.010

Ejemplares similares